A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.

Aelis Farma, a France-based drug developer spun out of Inserm, has listed on Euronext Paris following a €25m ($28.1m) initial public offering. Aelis Farma’s shareholders include Inserm’s tech transfer office, Inserm Transfert Initiative, which had helped the spinout raise a total of $14m prior to the flotation.

Dive Technologies, a US-based subsea robotics developer that is collaborating with Virginia Tech, has agreed to an acquisition by defence technology producer Anduril Industries for an undisclosed amount. Dive Technologies had obtained…